Pancreatic Cancer Clinical Trials
Find clinical trials for pancreatic cancer. Search for pancreatic cancer clinical trials in different cities and states across the United States.
GENOCARE: a Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual CareGENOCARE: a Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care
Sponsor:
Reema A. Patel
Location:
Code:
NCT05391126
Conditions
Colorectal Cancer
Pancreatic Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Irinotecan
Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples from Colorectal Cancer PatientsGastrointestinal Biomarkers in Tissue and Biological Fluid Samples from Colorectal Cancer Patients
Sponsor:
Vanderbilt University Medical Center
Location:
Code:
NCT00899626
Conditions
Colorectal Cancer
Esophageal Cancer
Gastric Cancer
Pancreatic Cancer
Precancerous Condition
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Coordinating and Data Management Center for the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic CancerCoordinating and Data Management Center for the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer
Sponsor:
M.D. Anderson Cancer Center
Location:
Code:
NCT03058926
Conditions
Chronic Pancreatitis
Diabetes
Pancreatic Cancer
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted
Interventions
Data Management and Monitoring
Improving Outcomes in Cancer Patients With a Nutritional and Physical Conditioning Prehabilitation ProgramImproving Outcomes in Cancer Patients With a Nutritional and Physical Conditioning Prehabilitation Program
Sponsor:
McGill University Health Centre/Research Institute of the McGill University Health Centre
Location:
Code:
NCT03475966
Conditions
Pancreatic Cancer
Liver Cancer
Bile Duct Cancer
Hepatobiliary Cancer
Surgery
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Exercise
Nutrition
Relaxation techniques
A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDACA Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC
Sponsor:
Genentech, Inc.
Location:
Code:
NCT05968326
Conditions
Adenocarcinoma, Pancreatic Ductal
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Autogene cevumeran
Atezolizumab
mFOLFIRINOX
Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSELutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE
Sponsor:
ITM Solucin GmbH
Location:
Code:
NCT04919226
Conditions
Neuroendocrine Tumors
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
177Lu-Edotreotide (Peptide Receptor Radionuclide Therapy) PRRT
CAPTEM (Capecitabine and Temozolomide)
Amino-Acid Solution
Everolimus
FOLFOX (Folinic acid + Fluorouracil + Oxaliplatin)
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 PatientsAdministering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT03745326
Conditions
Gastrointestinal Cancer
Pancreatic Cancer
Gastric Cancer
Colon Cancer
Rectal Cancer
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Cyclophosphamide
Fludarabine
Aldesleukin
anti-KRAS G12D mTCR PBL
First in Human Study of TORL-2-307-ADC in Participants With Advanced CancerFirst in Human Study of TORL-2-307-ADC in Participants With Advanced Cancer
Sponsor:
TORL Biotherapeutics, LLC
Location:
Code:
NCT05156866
Conditions
Advanced Solid Tumor
Gastric Cancer
Pancreas Cancer
Gastroesophageal Junction Adenocarcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
TORL-2-307-ADC
A Phase I Dual Dose Escalation Study of Radiation and Nab-Paclitaxel in Patients With Unresectable and Borderline Resectable Pancreatic CancerA Phase I Dual Dose Escalation Study of Radiation and Nab-Paclitaxel in Patients With Unresectable and Borderline Resectable Pancreatic Cancer
Sponsor:
Abramson Cancer Center at Penn Medicine
Location:
Code:
NCT02207465
Conditions
Locally Advanced Unresectable Pancreatic Cancer Treated With Chemoradiotherapy
Borderline Resectable Pancreatic Cancer Treated With Chemoradiotherapy
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Radiotherapy
Abraxane
Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal AdenocarcinomaStudy of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
Sponsor:
Arcus Biosciences, Inc.
Location:
Code:
NCT06608927
Conditions
Metastatic Pancreatic Ductal Adenocarcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Quemliclustat
Placebo
Nab-paclitaxel
Gemcitabine